GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR
Revakinagene Taroretcel Reduces Ellipsoid Zone Area in Macular Telangiectasia Type 2
Reduced ellipsoid zone area seen with revakinagene taroretcel compared with sham procedure
Increase Seen in Physician Visits ~15 Years Before MS Onset
All-cause physician visit rate ratios consistently elevated from 14 years before onset, peaking in the year before MS onset
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
Trials show once-daily drops are safe and effective
GLP-1 Receptor Agonist Use Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
Association seen in seniors with type 2 diabetes; greater associations seen for semaglutide and liraglutide
Corticosteroids Not Superior to Placebo for Add-On Treatment of Bacterial Keratitis
Adjunctive corticosteroids not superior to placebo, while adjunctive corneal cross-linking associated with increased scar size
Indicators of Neuropathic Ocular Pain Identified After LASIK
Indicators include persistent high corneal tactile sensitivity postanesthesia, reduced nerve density, increased microneuroma density in central cornea
ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy
The EfficientNetB0 achieved more than 99 percent accuracy, with image processing speed <1 second per image
Diversified Segmental Defocus Optimization Spectacles Delay Myopia in Children
Addition of 0.01 percent atropine did not increase the efficacy of DSDO spectacle lenses
